Are you worried that memory loss is more than just ordinary forgetfulness? Or have you or a loved one been diagnosed with early stages of Alzheimer’s disease? If so, you might be interested in the TRAILBLAZER-ALZ Study.
The TRAILBLAZER-ALZ Study will examine if 2 investigational drugs, either alone or used together, may help to slow or stop memory loss. This is a novel approach, because it will be the first time researchers have looked at these 2 investigational drugs together. Researchers want to investigate if using both drugs together might work better than using just one.
The TRAILBLAZER-ALZ Study will include about 375 participants in the United States and Canada.
There is no cost to participate. Participants will receive all study-related care from a research doctor at no cost, and may be compensated per study site visit for time and travel expenses. Transportation to and from your appointments will be provided at no cost through LYFT.
Who can join the TRAILBLAZER-ALZ Study?
You may be able to take part if you:
- are 60–85 years of age
- have had memory loss for 6 months or more that has become gradually worse over time
- have a family member or close friend who is with you at least 10 hours per week and can attend study appointments with you.
If you are interested in joining this trial, click on the "Online Survey" button below to provide your contact information. One of our staff will be in touch with you within 24 hrs to conduct a short phone screen to determine your eligibility. Otherwise, you can call our center directly at (773) 275-3500 to speak with one of our staff today.